These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 39226128)

  • 1. Stability-indicating green HPLC method for fixed-dose tablets containing remogliflozin etabonate and teneligliptin: an AQbD approach.
    Patel R; Kotadiya R
    Drug Dev Ind Pharm; 2024 Aug; 50(8):750-762. PubMed ID: 39226128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability-indicating HPLC for remogliflozin, vildagliptin, and metformin: Method development, validation, and greenness.
    Acharya H; Kotadiya R
    Ann Pharm Fr; 2024 Nov; 82(6):1071-1081. PubMed ID: 38945392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivariate Analysis and Response Surface Modeling to Green Analytical Chemistry-Based RP-HPLC-PDA Method for Chromatographic Analysis of Vildagliptin and Remogliflozin Etabonate.
    Prajapati P; Prajapati B; Pulusu VS; Shah S
    J AOAC Int; 2023 May; 106(3):601-612. PubMed ID: 36651669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemometric-Based AQbD and Green Chemistry Approaches to Chromatographic Analysis of Remogliflozin Etabonate and Vildagliptin.
    Prajapati P; Ahir H; Prajapati B; Shah S
    J AOAC Int; 2022 Dec; 106(1):239-249. PubMed ID: 35822588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AQbD-guided development and validation of an innovative extraction procedure and stability-indicating RP-HPLC method for quantification of posaconazole in tablet formulation.
    Jadhav S; Wadher S
    Ann Pharm Fr; 2024 Nov; 82(6):1088-1102. PubMed ID: 39002855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QbD-Based Stability-Indicating RP-HPLC Method Development and Validation for the Estimation of Favipiravir-An Eco-Friendly Approach.
    Chandana M S; K S; A A; Narendra P; K S
    J AOAC Int; 2024 May; 107(3):377-386. PubMed ID: 38318977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of safety and tolerability of remogliflozin etabonate (GSK189075) when administered with total daily dose of 2000 mg of metformin.
    Dobbins R; Hussey EK; O'Connor-Semmes R; Andrews S; Tao W; Wilkison WO; Cheatham B; Sagar K; Hanmant B
    BMC Pharmacol Toxicol; 2021 Jun; 22(1):34. PubMed ID: 34120651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical Quality by Design-Based Robust RP-HPLC Method for Quantitative Estimation of Pregabalin and Etoricoxib in Fixed-Dose Combination Tablet Formulation.
    Shah J; Kotadiya R; Patel R
    J AOAC Int; 2022 Oct; 105(6):1536-1547. PubMed ID: 35766798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DoE-Based Analytical Failure Modes Critical Effect Analysis (AFMCEA) to a Multipurpose-RP-HPLC Method for the Estimation of Multiple FDC Products of Metformin Hydrochloride Using an Analytical Quality by Design Approach.
    Prajapati PB; Mistry KY; Shah SA
    J AOAC Int; 2022 Jun; 105(4):986-998. PubMed ID: 35176154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial.
    Dharmalingam M; Aravind SR; Thacker H; Paramesh S; Mohan B; Chawla M; Asirvatham A; Goyal R; Shembalkar J; Balamurugan R; Kadam P; Alva H; Kodgule R; Tandon M; Vaidyanathan S; Pendse A; Gaikwad R; Katare S; Suryawanshi S; Barkate H
    Drugs; 2020 Apr; 80(6):587-600. PubMed ID: 32162274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability-Indicating HPTLC Method for Determination of Remogliflozin Etabonate and Vildagliptin in Tablets.
    Muruganathan G; Thangavel M; Kochupapy RT
    J Chromatogr Sci; 2023 Dec; 62(1):27-34. PubMed ID: 36670546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of experimental design in HPLC method optimization and robustness for the simultaneous determination of canagliflozin, empagliflozin, linagliptin, and metformin in tablet.
    Moussa BA; Mahrouse MA; Fawzy MG
    Biomed Chromatogr; 2021 Oct; 35(10):e5155. PubMed ID: 33949720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability-indicating RP-HPLC method development and validation for determination of nine impurities in apixaban tablet dosage forms. Robustness study by quality by design approach.
    Subramanian VB; Katari NK; Dongala T; Jonnalagadda SB
    Biomed Chromatogr; 2020 Jan; 34(1):e4719. PubMed ID: 31634417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability-indicating ultra performance liquid chromatography method development and validation for simultaneous estimation of metformin, linagliptin, and empagliflozin in bulk and pharmaceutical dosage form.
    Vankalapati KR; Alegete P; Boodida S
    Biomed Chromatogr; 2021 Apr; 35(4):e5019. PubMed ID: 33146442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of DoE and Risk-Based Enhanced Analytical Quality by Design Approach to Stability-Indicating RP-HPLC Method for Stability Study of Bosutinib.
    Prajapati PB; Bagul N; Kalyankar G
    J AOAC Int; 2021 Dec; 104(6):1742-1753. PubMed ID: 34100929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple and Sensitive RP-HPLC and UV Spectroscopic Methods for the Determination of Remogliflozin Etabonate in Pure and Pharmaceutical Formulations.
    Itigimatha N; Chadchan KS; Yallur BC; Hadagali MD
    Turk J Pharm Sci; 2022 Apr; 19(2):213-219. PubMed ID: 35510349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of a Stability Indicating RP-HPLC Method for Simultaneous Estimation of Teneligliptin and Metformin.
    Vetapalem R; Yejella RP; Atmakuri LR
    Turk J Pharm Sci; 2020 Apr; 17(2):141-147. PubMed ID: 32454773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validated stability-indicating RP-HPLC method for the determination of rimonabant in a pharmaceutical dosage form.
    Hurtado FK; Ravanello A; Arend MZ; Wrasse M; Dalmora SL; Rolim CM
    J AOAC Int; 2010; 93(3):869-75. PubMed ID: 20629389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of stability-indicating HPLC method and accelerated stability studies for osmotic and pulsatile tablet formulations of Clopidogrel Bisulfate.
    Deshmukh PR; Gaikwad VL; Tamane PK; Mahadik KR; Purohit RN
    J Pharm Biomed Anal; 2019 Feb; 165():346-356. PubMed ID: 30579235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DoE-Based Analytical-FMCEA for Enhanced AQbD Approach to MEER-RP-HPLC Method for Synchronous Estimation of 15 Anti-Hypertensive Pharmaceutical Dosage Forms.
    Prajapati PB; Patel AS; Shah SA
    J AOAC Int; 2022 Feb; 105(1):34-45. PubMed ID: 34293098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.